3 Patents
- US119999932024Use of Biomarkers in Identifying Cancer Patients That Will Be Responsive to Treatment with a PRMT5 Inhibitor
Janssen Pharmaceutica NV
0 cites - US119936142024Monocyclic and Bicyclic Ring System Substituted Carbanucleoside Analogues for Use as PRMT5 Inhibitors
Janssen Pharmaceutica NV
0 cites - US1188336720246-6 Bicyclic Aromatic Ring Substituted Nucleoside Analogues for Use as PRMT5 Inhibitors
Janssen Pharmaceutica NV
0 cites